|
Related Companies
|
[ECZYT, INTEM]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
Atalay M. Gümrah, who is the CEO of Eczacıbaşı Group (Group) and the General Manager of our main shareholder Eczacıbaşı Holding AŞ (Holding), will resign from his positions as of 31.12.2024 due to his own preferences and health issues. Atalay M. Gümrah, will continue to serve as an Advisor to the Chairman of the Holding. In the transition period, the Group senior management will work directly under the leadership of F. Bülent Eczacıbaşı, Chairman of the Holding.
This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||